{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:38:56Z","timestamp":1783708736565,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jcms.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,20]],"date-time":"2015-12-20T09:45:11Z","timestamp":1450604711000},"page":"265-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients"],"prefix":"10.1016","volume":"44","author":[{"given":"Adepitan A.","family":"Owosho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin","family":"Kadempour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaeHee K.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeez","family":"Farooki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fornier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-6264","authenticated-orcid":false,"given":"Joseph M.","family":"Huryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry L.","family":"Estilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcms.2015.12.005_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"34","key":"10.1016\/j.jcms.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"issue":"6937","key":"10.1016\/j.jcms.2015.12.005_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-009-0047-9","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid","volume":"27","author":"Cetiner","year":"2009","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.jcms.2015.12.005_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jcms.2015.12.005_bib8","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen Dent"},{"issue":"7","key":"10.1016\/j.jcms.2015.12.005_bib9","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jcms.2015.12.005_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"J\u00a0Am Dent Assoc"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"24","key":"10.1016\/j.jcms.2015.12.005_bib12","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.jcms.2015.12.005_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1634\/theoncologist.2008-0091","article-title":"Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy","volume":"13","author":"Estilo","year":"2008","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"9768","key":"10.1016\/j.jcms.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jcms.2015.12.005_bib16","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates","volume":"27","author":"Fizazi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"9992","key":"10.1016\/j.jcms.2015.12.005_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.jcms.2015.12.005_bib19","article-title":"NCCN task force report: bone health in cancer care","volume":"7","author":"Gralow","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.jcms.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"J\u00a0Am Dent Assoc"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib21","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.jcms.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.jcms.2015.12.005_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcms.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05771.x","article-title":"Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients","volume":"1218","author":"Hoff","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jcms.2015.12.005_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"issue":"28","key":"10.1016\/j.jcms.2015.12.005_bib26","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jcms.2015.12.005_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","article-title":"Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene","volume":"67","author":"Lehrer","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712591003604708","article-title":"Denosumab\u2014an emerging treatment for postmenopausal osteoporosis","volume":"10","author":"Lewiecki","year":"2010","journal-title":"Expert Opin Biol Ther"},{"issue":"16","key":"10.1016\/j.jcms.2015.12.005_bib29","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"issue":"28","key":"10.1016\/j.jcms.2015.12.005_bib30","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","article-title":"Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases","volume":"25","author":"Lipton","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.jcms.2015.12.005_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.oooo.2012.08.439","article-title":"The relationship of denosumab pharmacology and osteonecrosis of the jaws","volume":"114","author":"Malan","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"11","key":"10.1016\/j.jcms.2015.12.005_bib32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2015.12.005_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/adj.12217","article-title":"Denosumab and osteonecrosis of the jaws \u2013 the pharmacology, pathogenesis and a report of two cases","volume":"59","author":"O'Halloran","year":"2014","journal-title":"Aust Dent J"},{"issue":"7","key":"10.1016\/j.jcms.2015.12.005_bib35","first-page":"621","article-title":"Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis","volume":"46","author":"Ohga","year":"2015","journal-title":"Quintessence Int"},{"issue":"10","key":"10.1016\/j.jcms.2015.12.005_bib36","first-page":"3707","article-title":"Osteonecrosis of the jaw in patient with denosumab therapy","volume":"7","author":"Olate","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"10.1016\/j.jcms.2015.12.005_bib37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"12","key":"10.1016\/j.jcms.2015.12.005_bib38","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.oraloncology.2015.08.014","article-title":"Osteonecrosis of the jaw a new complication related to ipilimumab","volume":"51","author":"Owosho","year":"2015","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib39","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jcms.2012.10.014","article-title":"Denosumab osteonecrosis of the mandible: a new entity? A case report","volume":"41","author":"Pichardo","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2015.12.005_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jcms.2015.12.005_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"10","key":"10.1016\/j.jcms.2015.12.005_bib42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.jcms.2015.12.005_bib43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jcms.2015.12.005_bib44","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcms.2015.12.005_bib45","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jcms.2015.12.005_bib46","first-page":"5","article-title":"Cancer statistics","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib47","first-page":"712","article-title":"Cost-effectiveness of denosumab vs. zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States","volume":"15","author":"Stopeck","year":"2012","journal-title":"J\u00a0Med Econ"},{"issue":"1","key":"10.1016\/j.jcms.2015.12.005_bib48","first-page":"447","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Support Care Cancer"},{"issue":"35","key":"10.1016\/j.jcms.2015.12.005_bib49","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/COC.0b013e31824be20e","article-title":"Efficacy and safety of denosumab versus zoledronic acid in patients with bone metastases: a systematic review and meta-analysis","volume":"36","author":"Sun","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jcms.2015.12.005_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"8","key":"10.1016\/j.jcms.2015.12.005_bib52","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2015.12.005_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cden.2013.12.006","article-title":"Antiresorptive drug-related osteonecrosis of the jaw","volume":"58","author":"Uyanne","year":"2014","journal-title":"Dent Clin North Am"},{"issue":"32","key":"10.1016\/j.jcms.2015.12.005_bib54","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.jcms.2015.12.005_bib55","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.21509","article-title":"An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma","volume":"84","author":"Vij","year":"2009","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jcms.2015.12.005_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients","volume":"115","author":"Watters","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"10.1016\/j.jcms.2015.12.005_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clbc.2012.04.001","article-title":"Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastases","volume":"12","author":"Xie","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"10.1016\/j.jcms.2015.12.005_bib58","first-page":"621","article-title":"Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases","volume":"17","author":"Xie","year":"2011","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.jcms.2015.12.005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2015.07.017","article-title":"Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics","author":"You","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"10.1016\/j.jcms.2015.12.005_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518215004199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518215004199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:33:08Z","timestamp":1760884388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518215004199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1010518215004199"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2015.12.005","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}